Synonyms: 5-((4-(2-methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate; Avandia; 5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione; API0006964; BCP9000017; CS-1088; DB00412; MCULE-8293284864; MP-0331; NSC-758698; RTC-064102; SB17326; VA11695; Brl-49653; 2,4-Thiazolidinedione, 5-004-02-((((methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-; NCGC00095124-02; NCGC00095124-03; NCGC00095124-04; NCGC00095124-05; NCGC00095124-06; NCGC00095124-08; 4CA-1110; AN-12970; BR-72839; Rosiglizole; CC-34292; HY-17386; SC-19017; BCP0726000232; AB0011992; AB2000652; AX8017813; LS-151340; FT-0602578; R0106; Rosiglitazone maleate; S2556; ST24029274; SW197573-6; 20R734; 6P-065; D08491; J10213; S00306; AB00698473-15; AB00698473-17; Brl 49653; AB00698473-18; AB00698473-19; AB00698473_20; AB00698473_21; AB00698473_22; AB00698473_23; C-20817; I06-0141; SR-01000763023-5; SR-01000763023-6; rosiglitazone (Avandia); BRD-A97437073-001-02-3; BRD-A97437073-001-03-1; BRD-A97437073-001-04-9; SR-01000763023-12; (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion; 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4dione; 5-[4-[2-[Methyl(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione; IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin); (+/-)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione; 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI); BRL49653; 5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione; 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy]phenyl]methyl]-2,4-thiazolidinedione; 5-[[4-[2-(methyl-pyridin-2-ylamino)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; 5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione; 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione; 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]phenyl methyl]thiazolidine-2,4-dione; ROSIGLITAZONE HCl; UNII-05V02F2KDG; Rosiglitazone hydrochloride; CHEMBL121; rosiglitazona; 05V02F2KDG; CID77999; C18-H19-N3-O3-S; ACN-034462; CS-O-02247; 2255B; A4304; C089730; D000077154; 5-(4-[2-(METHYL-PYRIDIN-2-YL-AMINO)-ETHOXY]-BENZYL)-THIAZOLIDINE-2,4-DIONE; rosiglitazonum; 5-[4-[2-[N-methyl-N-(2-pyridinyl)amino]ethoxy]benzyl]-2,4-thiazolidinedione; RGZ; RSG; Avandaryl; BRL 49653; TDZ 01; Rosiglitazone [INN:BAN]; Avandamet; CHEBI:50122; Rosigilitazone; 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione; 5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate; C18H19N3O3S; YASAKCUCGLMORW-UHFFFAOYSA-N; 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-; BRL-49653; MFCD00871760; NCGC00095124-01; AK-72839; 5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione; DSSTox_CID_17131; DSSTox_RID_79303; DSSTox_GSID_37131; Q-201681; 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione; 2,4-thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-; BRL49653; 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]-phenyl]methyl]-2,4-thiazolidine-dione; CAS-122320-73-4; SR-01000763023; Rosiglitazon; Rezult; Rosi; HSDB 7555; Rosiglitazone base; 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione; 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione; rosiglitazone; 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; 5-[4-[2-[N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione; Rosigliazone maleate; Gaudil (TN); Rosiglitazone-Avandia; Rosiglitazone (INN); Spectrum_001703; 155141-29-0; Spectrum2_001241; Spectrum3_000997; rosiglitazone maleate; Spectrum4_001125; Spectrum5_001464; Avandia;BRL-49653; AC1L2U9N; SCHEMBL5169; BSPBio_002693; KBioGR_001609; KBioSS_002183; KSC914G9L; SPECTRUM1504263; rosiglitazone; SPBio_001142; GTPL1056; DTXSID7037131; SCHEMBL14383595; CTK8B4395; KBio2_002183; KBio2_004751; KBio2_007319; KBio3_001913; KS-00000IPU; 122320-73-4; Rosiglitazone, >=98% (HPLC); HMS1922J11; HMS2094O13; HMS3649G08; HMS3656K16; Pharmakon1600-01504263; ACT04332; BCP03047; Tox21_111434; ANW-44906; Avandia; BBL029079; BDBM50030474; BG0432; CCG-39102; GP6434; NSC758698; STL350047; AKOS015894872; Tox21_111434_1; AC-3459;